Third Blood Pressure Medication, Losartan, Recalled

The FDA announced a third blood pressure medication recall because of possible contamination that can cause cancer. Sandoz Inc. is “voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA),” which is a “probable human carcinogen, according to the International Agency for Research on Cancer.” Losartan affected by the recall is 100 milligram/25-milligram tablets with the lot number JB8912.

THANK YOU FOR YOUR MESSAGE

One of our associates will follow up with you shortly